• China’s ONLY senior clinical development event on quality drug development operation
  •  CO-LOCATED with 2 closely-related events: customize your own conference agenda!
  •   China’s FIRST EVER CRO Leadership Forum – Hear Exclusively From Local CRO Leaders!

IBC’s Clinical Trials China will be focused on best practices in clinical trial project management and operational excellence for China focusing on trial quality, medical communication and overall drug development in China.

Learn about how to smoothly integrate China operations into global clinical trials with focus on maintaining trial quality and timeline. If you oversee trial management, protocol design, clinical operations, medical affairs, CRO partnerships, clinical strategy, data management, site monitoring, on-site operations or clinical development for pharma company, biotech, medical device or CRO, this is an event you cannot miss!

Clinical Trials China will be a part of PharmaCon China 2016, the only senior industry gathering in China for accelerating global and regional drug development operations and quality clinical processes in China taking place from 28th to 31st March 2016.

Key Topics Addressed:

  • How Does China Fit into the Global Development Pathway for Big Pharma and Regional Biotech?
  • Regulatory Updates on Clinical Trials in Asian Countries
  • How to Make the Successful Transition from Registration Trials to Phase IV Studies?
  • Good Clinical Practice (GCP) and Trial Monitoring Operations
  • Best Practices in Clinical Operations and Project Management for China
  • Quality Trial Data Operations
  • Working With Partners and Stakeholders to Accelerate Trial Timelines in China


View full agenda »




中国临床试验国际峰会 PharmaCon China 2016 的组成部分。PharmaCon China 2016 将于2016年3月28日至31日期间举行,是唯一一场在中国举行的资深业内人士聚集的专业会议,旨在加速全球及区域性的药物开发项目运作和中国高质量的临床流程。


  • 中国如何融入大型制药公司和区域生物技术企业的全球发展途径
  • 亚洲各国有关临床试验的法规更新
  • 如何从注册临床试验成功过渡到第四阶段研究?
  • 药物临床试验质量管理规范(GCP)与试验监测运作
  • 中国在临床运作和项目管理方面的最佳实践
  • 质量试验数据操作
  • 与合作伙伴及利益相关者携手合作,以加速中国的试验时间安排

查看完整议程 »


A Stellar Line Up of Speakers Include:

Li Chen
Hua Medicine, China
Xian Ping Lu
Shenzhen Chipscreen Biosciences, China
Ye Hua
Senior Vice President, Clinical Development and Regulatory Affairs
Hutchison Medipharma, China
Weikang Tao
CEO, R&D Centre
Shanghai Hengrui Medicine, China
Ming-Qiang Zhang
Corporate Vice-President, Research & Development
Amgen, China
Ming-Chu Hsu
Chairman of the Board & CEO
TaiGen Biotechnology, Taiwan
Joan Shen
Vice President, Development Head China R&D and Scientific Affairs
Janssen Pharmaceuticals, China
Friedhelm Blobel
SciClone Pharmaceuticals, USA & China
Dan Paulson
Vice President, Global Clinical Development, Group Head, Cardiometabolism Risk Management and Antiinfectives
Bayer HealthCare Pharmaceuticals, China
Christina Bodurow
Senior Director, External Sourcing, Development Center of Excellence
Eli Lilly and Co, USA

View all speakers »



Produced byBronze SponsorSession Spotlight Sponsor
Supporting Associations 
Media Partners  

International Marketing Partner